| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate |
2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df85162525a152e0bdcc62a18e79cd48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dedf41263209f37a1ccf32c17a16041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efc3f1bf81f114cf17b8750ee2ae5f8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4462e372614b34a47d499fc03eaf4c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f7050df25386db2a99bbbd22863f194 |
| publicationDate |
2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120105423-A |
| titleOfInvention |
How to identify patients with increased likelihood to respond to anticancer drugs |
| abstract |
The present invention provides methods for identifying patients with increased likelihood to respond to anticancer agents or patients with increased likelihood to undergo metastasis. The invention also provides a method of monitoring a patient's response to an anticancer agent. The invention also provides kits and articles of manufacture for use in the method. |
| priorityDate |
2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |